Inhalation

INH1026

Issue link: https://www.e-digitaleditions.com/i/1546950

Contents of this Issue

Navigation

Page 13 of 43

12 OctOber 2026 Inhalation connected to the system. e motor's rotation speed was regulated by a Mitsubishi S 300-type controller (Tokyo, Japan). Air and drug particles were drawn through a system consisting of the inhaler, an add-on piece (used in certain measurements) and a hollow upper airway model internally coated with glycerol. is system was connected to an isokinetic sampler and a Grimm Model 11A optical particle counter (Grimm Aerosol Technik, Ainring, Germany). e setup was further supplemented by a variable ejector- type cascade dilutor, a flow meter and a final, zero- count filter designed to capture the drug particles exiting the system. e measurements were con- ducted at 30, 60 and 90 L/min volumetric flow rates. Two types of measurements were performed: (1) 60 measurements without add-ons but with an upper airway replica to determine the filtering efficiency of the upper airways without utilization of add-ons (4 drugs × 3 flow rates × 5 repetitions) and (2) a total of 360 measurements (6 add-on types × 4 drugs × 3 flow rates × 5 repetitions) with the add-ons attached to the inhalers and the upper airway geometry to see the effect of add-ons on the amount of drug that can avoid deposition in the upper airways. From these measurements, the ratio of the change of the drug mass reaching the lungs due to different add-ons to the mass entering the lungs without add-ons (relative change) could be calculated. Results and discussions CFPD simulations for the optimization of add-on sizes and shapes and selection of potential add-on spacer candidates Numerical simulations enabled both the optimiza- tion and evaluation of the add-on geometries. In the absence of an add-on, the complex airflow patterns emerging from the inhaler outlets resulted in high impactor measurements retrieved in the open liter- ature, while their shape was spherical. A one-way coupling between the phases was assumed: the air- stream influenced the particle trajectories but the particles had no effect on the airflow field. Air- flow characteristics—including velocity, pressure, turbulence intensity and dissipation rate—were computed across 3-3.5 million control volumes (depending on the inhaler). Drug particle trans- port was simulated in geometries both with and without the inhaler add-ons and the corresponding upper airway filtration efficiencies were compared. Based on the simulation results, the number of the potential add-on candidates was reduced. e add-ons consistently increasing or only insignifi- cantly decreasing the upper airway deposition were excluded from further investigations. Experimental particle deposition measurements e efficiency of the 3D-printed add-ons connected to the four inhalers was further evaluated through experimental measurements of particle concentra- tion and size distribution at both the inhaler mouth- piece and the outlet of the upper airway model, with and without the add-ons attached. e amount of drug deposited in the upper airways—or in the com- bined system of the upper airways and the add-on— was determined by calculating the size-fractionated difference in particle concentrations between these two locations. A schematic representation of the experimental setup can be seen in Figure 2 (left side) together with the real-life laboratory equipment (right side). e following describes the main components of the setup: A high-volume pump was operated by a three- phase, high-performance electric motor, enabling wide-range airflow to be controlled through the tubes Figure 2 Schematic representation of the experimental setup for aerosol deposition measurements Add-on Hollow airway DPI inhaler Isokinetic sampling Dilutor Optical particle counter Extration Filter Flow meter Pump Controller

Articles in this issue

view archives of Inhalation - INH1026